Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
Status:
Not yet recruiting
Trial end date:
2024-08-17
Target enrollment:
Participant gender:
Summary
Study based on the pharmacokinetic, pharmacodynamic, safety and stability evaluation of 3
standardized formulations of THC, to be used in healthy volunteers and post-chemotherapy
patients as an adjuvant in the symptomatic treatment of the latter in discomfort associated
with cancer treatment, with the aim of possible new therapeutic entities.